X

Trial Profile

Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dapagliflozin (Primary) ; Glipizide; Metformin
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms Hyper

Most Recent Events

29 Nov 2023 The protocol has been amended as above- 1) Number of treatment arms has been changed from 2 to 4. 2) Actual number of patients has been changed from 23 to 72.
02 Oct 2023 Status changed from active, no longer recruiting to completed.
26 Jun 2023 Results (n=24) presented at the 83rd Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com